China Universal Asset Management Co., Ltd. Phathom Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,499 shares of PHAT stock, worth $86,849. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,499
Previous 13,134
10.39%
Holding current value
$86,849
Previous $237,000
50.63%
% of portfolio
0.01%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding PHAT
# of Institutions
142Shares Held
74.8MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$60.6 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$44.7 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$42.3 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$24.5 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$20.9 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $235M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...